3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Genitourinary
1
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Resectable Localized Prostate Cancer
1
Recurrence
1
Radiation-induced Oral Mucositis
1
Prostate Cancer Recurrent
1
Pancreatic Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Hepatocellular
1
Adenocarcinoma of Lung
1
Interventions
Sirolimus
1
Nelfinavir
1
Metformin
1
Hydroxychloroquine
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Prostate Cancer Recurrent
×
Hydroxychloroquine
×
Clear all
NCT05036226
2026-05-13
COAST
Medical University of South Carolina
Phase 1/2
Recruiting
76 enrolled